Editor-in-Chief: Weidong Le
Indexing: CAS, Dimensions, Lens, CNKI,
Submission to first decision: 58 days

Ageing and Neurodegenerative Diseases

Exclusive Interview with Prof. Robert C. Bast: A Pioneer in Ovarian Cancer Research

19 0 1

Articles

Most Recent | Most Viewed | Most Downloaded

Updates on the management of neuroendocrine liver metastasis

Abstract:
Approximately one-third of patients diagnosed with a neuroendocrine tumor (NET) develop distant metastases, with the liver being the most common site.... MORE
Open Access Review DOI: 10.20517/2394-4722.2024.140 12 Jun 2025
Views: 16 Downloads: 1
Download PDF 0 0

A comprehensive study on the prognostic value of pyroptosis-associated genes in hepatocellular carcinoma

Abstract:
Aim: Hepatocellular carcinoma (HCC) is a prevalent malignancy globally, and pyroptosis, an inflammatory form of programmed cell death, is closely... MORE
Open Access Original Article DOI: 10.20517/2394-4722.2025.18 28 May 2025
Views: 112 Downloads: 15
Download PDF 0 0

A serum three-microRNA panel: promising biomarkers for renal cell carcinoma screening

Abstract:
Aim: Renal cell carcinoma (RCC) screening is helpful to improve the prognosis of patients. However, the existing RCC detection methods are not suitable... MORE
Open Access Original Article DOI: 10.20517/2394-4722.2024.122 26 Apr 2025
Views: 257 Downloads: 273
Download PDF 0 0

Serum TUBB is a potential biomarker for the diagnosis of non-small cell lung cancer

Abstract:
Aim: To identify serum biomarkers for non-small cell lung cancer (NSCLC) and assess their potential for early diagnosis.Experimental: MB-WCX... MORE
Open Access Original Article DOI: 10.20517/2394-4722.2024.127 23 Mar 2025
Views: 364 Downloads: 173
Download PDF 0 2

Predictive biomarkers for immunotherapy in gastric cancer

Abstract:
Gastric cancer remains a significant global health burden, and while immunotherapy offers promising therapeutic avenues, its efficacy varies greatly among... MORE
Open Access Review DOI: 10.20517/2394-4722.2024.107 20 Mar 2025
Views: 400 Downloads: 313
Download PDF 0 3

Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness

Abstract:
Ovarian cancer remains the most lethal gynecologic malignancy in the USA. For over twenty years, epithelial-mesenchymal transition (EMT) has been characterized... MORE
Open Access Review DOI: 10.20517/2394-4722.2023.34 29 Jun 2023
Views: 1893 Downloads: 1148
Download PDF 4 13

Application of radiomics and artificial intelligence in lung cancer immunotherapy: a guide and hurdles from clinical trials

Abstract:
Immunotherapy has shown promising results with improved progression-free survival and overall survival in lung cancer. However, novel immunotherapy could... MORE
Open Access Review DOI: 10.20517/2394-4722.2023.10 6 Aug 2023
Views: 983 Downloads: 715
Download PDF 1 23

Current diagnosis and management of cardiac melanoma: a case series and review

Abstract:
Malignant melanoma is believed to have the highest rate of cardiac metastasis of any cancer based on autopsy studies, but descriptions of clinical findings,... MORE
Open Access Case Report DOI: 10.20517/2394-4722.2022.113 6 Jul 2023
Views: 1221 Downloads: 619
Download PDF 1 12

Proceedings of the 10th International Congress on Cancer Metastasis

Submission Deadline: 30 Nov 2025

Published articles: 0

We are honored to invite Prof. Atkins to share his academic journey with us.
On March 20, 2025, the Journal of Cancer Metastasis and Treatment (JCMT) has been officially included in the Chinese Academy of Sciences (CAS) Journal Ranking system.
The 10th iteration of the Congress brings together international experts in oncology, immunobiology, pharmacology, molecular biology, and molecular imaging to discuss preclinical, translational, and clinical advances in diagnosing, treating and preventing cancer metastasis.
In 2024, JCMT achieved significant growth and success, thanks to the collective efforts of its editorial team, authors, reviewers, event participants, readers, and staff. Their collaboration has greatly enhanced the journal’s progress and reputation within its field.
To celebrate this milestone, we have organized a series of special content and events to commemorate JCMT's decade of advancing cancer research.
We are honored to invite Prof. Atkins to share his academic journey with us.
On March 20, 2025, the Journal of Cancer Metastasis and Treatment (JCMT) has been officially included in the Chinese Academy of Sciences (CAS) Journal Ranking system.

Exclusive Interview with Prof. Robert C. Bast: A Pioneer in Ovarian Cancer Research

19 0 1

Proceedings of the 10th International Congress on Cancer Metastasis

Submission Deadline: 30 Nov 2025

Published articles: 0

Ageing and Neurodegenerative Diseases
ISSN 2769-5301 (Online)

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will be preserved here permanently:

https://www.portico.org/publishers/oae/